HealthDay on MSN1d
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...
Bariatric surgeries drop sharply as people turn to Wegovy, Saxenda for weight loss
The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...
GlobalData on MSN2d
Allurion boasts over 17% weight loss with swallowable balloon device
A study noted an average weight loss of 17.6% with Allurion’s device in patients who had no or less than 5% weight loss with ...
Dad, 58, died after taking ‘miracle’ weight loss drug for just 19 days to ‘confidently walk daughter down the aisle’
A DAD died after taking a weight loss jab for just a few weeks. Tim Ramsay, from South Australia, wanted to shed some pounds so he could confidently walk his daughter down the aisle. The ...
WebMD20h
New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
theasianparent.com9d
What’s with all the new weight loss medications? Your Guide to Understanding GLP-1 Receptor Agonists
Drugs such as Wegovy, Ozempic, and Saxenda have quickly become household names. But are these weight loss medications right ...
AOL13d
Bariatric surgeries drop sharply as people turn to Wegovy, Saxenda for weight loss
The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.
Daily2h
Bariatric surgery imore cost effective than newer weight loss drugs alone, finds study
Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...